Harrow Health, Inc.
Harrow Health, Inc. (HROW) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · HROW · as of Jun 8, 2026
Activity summary
Buy transactions
4
P-Purchase only
Sell transactions
6
12 Months
Buy/Sell ratio
0.67
Buy/Sell (by trades)
Overall sentiment
Harrow Health, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
HROW insider buying and selling by quarter
HROW insider selling · HROW insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · HROW ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
HROW executive sell shares · HROW board member insider trading · HROW insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 18, 2026 | Graves Adrienne L Director | Purchase | 1,000 | $31K | Form 4 |
| May 18, 2026 | SILVERNAIL LAUREN P Director | Purchase | 1,000 | $31K | Form 4 |
| May 14, 2026 | BAUM MARK L CHIEF EXECUTIVE OFFICER · Director | Purchase | 10,000 | $302K | Form 4 |
| May 14, 2026 | BOLL ANDREW R. PRESIDENT AND CFO | Purchase | 3,500 | $105K | Form 4 |
| Dec 12, 2025 | BOLL ANDREW R. PRESIDENT AND CFO | Option | 60,000 | $237K | Form 4 |
| Dec 12, 2025 | BOLL ANDREW R. PRESIDENT AND CFO | Other | 26,665 | $1.25M⚡ | Form 4 |
| Dec 12, 2025 | BAUM MARK L CHIEF EXECUTIVE OFFICER · Director | Option | 180,000 | $711K | Form 4 |
| Dec 12, 2025 | BAUM MARK L CHIEF EXECUTIVE OFFICER · Director | Other | 79,994 | $3.76M⚡ | Form 4 |
| Apr 3, 2025 | BOLL ANDREW R. CFO | Option | 346,500 | — | Form 4 |
| Apr 7, 2025 | BOLL ANDREW R. CFO | Other | 136,745 | $3.16M⚡ | Form 4 |
| Apr 3, 2025 | SAHAREK JOHN P. CEO & President, ImprimisRx | Option | 277,200 | — | Form 4 |
| Apr 7, 2025 | SAHAREK JOHN P. CEO & President, ImprimisRx | Other | 109,475 | $2.53M⚡ | Form 4 |
| Apr 3, 2025 | BAUM MARK L CEO · Director | Option | 762,300 | — | Form 4 |
| Apr 7, 2025 | BAUM MARK L CEO · Director | Other | 300,363 | $6.94M⚡ | Form 4 |
| Nov 16, 2023 | BAUM MARK L CEO · Director | Purchase | 7,500 | $61K | Form 4 |
| Nov 10, 2023 | SAHAREK JOHN P. Chief Commercial Officer | Option | 20,000 | — | Form 4 |
| Nov 10, 2023 | SAHAREK JOHN P. Chief Commercial Officer | Other | 9,778 | $125K | Form 4 |
| Aug 14, 2023 | BAUM MARK L CEO · Director | Purchase | 5,800 | $99K | Form 4 |
| Aug 14, 2023 | Makary Martin A. Director | Purchase | 20,000 | $338K | Form 4 |
| Jul 18, 2023 | BAUM MARK L CEO · Director | Option | 762,300 | — | Form 4 |
| Jul 18, 2023 | BAUM MARK L CEO · Director | Other | 299,968 | $5.47M⚡ | Form 4 |
| Jul 18, 2023 | SAHAREK JOHN P. Chief Commercial Officer | Option | 277,200 | — | Form 4 |
| Jul 18, 2023 | SAHAREK JOHN P. Chief Commercial Officer | Other | 109,080 | $1.99M⚡ | Form 4 |
BAUM MARK L
CHIEF EXECUTIVE OFFICER · Director
Date
May 14
Shares
10,000
Price
$30.20
Value
$302K
BOLL ANDREW R.
PRESIDENT AND CFO
Date
May 14
Shares
3,500
Price
$29.90
Value
$105K
BOLL ANDREW R.
PRESIDENT AND CFO
Date
Dec 12
Shares
60,000
Price
$3.95
Value
$237K
BOLL ANDREW R.
PRESIDENT AND CFO
Date
Dec 12
Shares
26,665
Price
$47.06
Value
$1.25M ⚡
BAUM MARK L
CHIEF EXECUTIVE OFFICER · Director
Date
Dec 12
Shares
180,000
Price
$3.95
Value
$711K
BAUM MARK L
CHIEF EXECUTIVE OFFICER · Director
Date
Dec 12
Shares
79,994
Price
$47.06
Value
$3.76M ⚡
SAHAREK JOHN P.
CEO & President, ImprimisRx
Date
Apr 3
Shares
277,200
Price
—
Value
—
SAHAREK JOHN P.
CEO & President, ImprimisRx
Date
Apr 7
Shares
109,475
Price
$23.09
Value
$2.53M ⚡
SAHAREK JOHN P.
Chief Commercial Officer
Date
Nov 10
Shares
20,000
Price
—
Value
—
SAHAREK JOHN P.
Chief Commercial Officer
Date
Nov 10
Shares
9,778
Price
$12.83
Value
$125K
SAHAREK JOHN P.
Chief Commercial Officer
Date
Jul 18
Shares
277,200
Price
—
Value
—
SAHAREK JOHN P.
Chief Commercial Officer
Date
Jul 18
Shares
109,080
Price
$18.23
Value
$1.99M ⚡
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About HROW insider trading
HROW insider trades
Harrow Health, Inc. (HROW) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including BAUM MARK L (CHIEF EXECUTIVE OFFICER · Director), BOLL ANDREW R. (PRESIDENT AND CFO), Graves Adrienne L (Director). Over the past 12 months, 4 insiders have filed transactions with the SEC. HROW insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Harrow Health, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
HROW insider trading · 5 questionsThe insiders of Harrow Health, Inc. (HROW) include executives and directors such as BAUM MARK L (CHIEF EXECUTIVE OFFICER · Director), BOLL ANDREW R. (PRESIDENT AND CFO), Graves Adrienne L (Director), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026